These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15220380)

  • 21. [The dynamic phenomenon of the heterogenicity of cancer cell populations and its clinicopathologic implications].
    Vera-Román JM
    Med Clin (Barc); 1987 Feb; 88(7):281-3. PubMed ID: 3561074
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.
    Komuro H; Saihara R; Shinya M; Takita J; Kaneko S; Kaneko M; Hayashi Y
    J Pediatr Surg; 2007 Dec; 42(12):2040-5. PubMed ID: 18082704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roots and stems: stem cells in cancer.
    Polyak K; Hahn WC
    Nat Med; 2006 Mar; 12(3):296-300. PubMed ID: 16520777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a side population of cancer cells from human gastrointestinal system.
    Haraguchi N; Utsunomiya T; Inoue H; Tanaka F; Mimori K; Barnard GF; Mori M
    Stem Cells; 2006 Mar; 24(3):506-13. PubMed ID: 16239320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of CD90+ cancer stem cells in human liver cancer.
    Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
    Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells in breast cancer and metastasis.
    Lawson JC; Blatch GL; Edkins AL
    Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
    Daley GQ
    Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Getting to the stem of cancer.
    Sánchez-García I
    Semin Cancer Biol; 2010 Apr; 20(2):63-4. PubMed ID: 20451615
    [No Abstract]   [Full Text] [Related]  

  • 29. Global mRNA analysis to determine a transcriptome profile of cancer stemness in a mouse model.
    Heffron CC; Gallagher MF; Guenther S; Sherlock J; Henfrey R; Martin C; Sheils O; O'Leary JJ
    Anticancer Res; 2007; 27(3A):1319-24. PubMed ID: 17593625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells as the engine of unstable tumor progression.
    Solé RV; Rodríguez-Caso C; Deisboeck TS; Saldaña J
    J Theor Biol; 2008 Aug; 253(4):629-37. PubMed ID: 18534628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying cancer stem cells in solid tumors: case not proven.
    Hill RP
    Cancer Res; 2006 Feb; 66(4):1891-5; discussion 1890. PubMed ID: 16488984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful therapy must eradicate cancer stem cells.
    Dingli D; Michor F
    Stem Cells; 2006 Dec; 24(12):2603-10. PubMed ID: 16931775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells: an old idea--a paradigm shift.
    Wicha MS; Liu S; Dontu G
    Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells in solid tumors: an overview.
    O'Brien CA; Kreso A; Dick JE
    Semin Radiat Oncol; 2009 Apr; 19(2):71-7. PubMed ID: 19249644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric and symmetric stem-cell divisions in development and cancer.
    Morrison SJ; Kimble J
    Nature; 2006 Jun; 441(7097):1068-74. PubMed ID: 16810241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
    Sánchez-García I; Vicente-Dueñas C; Cobaleda C
    Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine cells in non-endocrine tumours.
    Wright NA
    J Pathol; 1990 May; 161(1):85-7. PubMed ID: 2196351
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of microarray technologies on cytopathology. Overview of technologies and commentary on current and future implications for pathologists and cytopathologists.
    Rimm DL
    Acta Cytol; 2001; 45(2):111-4. PubMed ID: 11284295
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of morphometry for clinical diagnosis].
    Avtandilov GG
    Klin Med (Mosk); 1987 Jan; 65(1):8-12. PubMed ID: 3560835
    [No Abstract]   [Full Text] [Related]  

  • 40. A case for integrated morphomolecular diagnostic pathologists.
    Salto-Tellez M
    Clin Chem; 2007 Jul; 53(7):1188-90. PubMed ID: 17582150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.